Seres Therapeutics (MCRB) Q4 2022 Earnings

7MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.7
-0.62
-0.54
-0.46

Details

Expected EPS
-0.46
Actual EPS
-0.54
Surprise EPS
-0.08
Surprise Percent
+17.39%

Description

Seres Therapeutics (MCRB) has reported earnings of -0.54 per share for Q4 2022.

0 Comments

Share your thoughts